Valuation (12%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -11.94 | 35.87 |
PEG Ratio (TTM) | -0.42 | 0.18 |
P/S Ratio (TTM) | 0.09 | 1.78 |
P/B Ratio (TTM) | 10.91 | 0.57 |
P/FCF Ratio (TTM) | -0.36 | 14.45 |
Price to 5YR AVG Earnings Ratio | N/A | 84.36 |
Price to 5YR AVG FCF Ratio | N/A | 38.43 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -31.21% | 2.58% |
ROE (TTM) | -68.16% | 8.72% |
Net Profit Margin (TTM) | -24.13% | 6.53% |
ROIC 5YR AVG | N/A | 11.17% |
Growth (12%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 1.78% | -782.27% | N/A |
Revenue | -3.55% | 94.16% | N/A |
Net Income | 1.22% | -47.97% | N/A |
Cash Flow | -216.36% | -40.54% | N/A |
Health (35%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.26 | 1.87 |
Quick Ratio (TTM) | 1.38 | 1.33 |
D/E Ratio (TTM) | 1.63 | -0.18 |
Interest Coverage (TTM) | -4.12 | 6.03 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | N/A | 2.59 |
LTL to 5YR AVG FCF | N/A | 2.97 |
Shares Outstanding Growth 5YR AVG | N/A | -8.77% |